NVS · CUSIP 66987V109
Novartis AG
Reported by 5 of 79 curated managers in Q2 2026, in the holdings snapshot last exported 2026-10-26.
- Managers holding
- 5
- Average portfolio weight
- 0.3%
- Combined reported value
- $136.8M
- Research group
- 79
5 of the 79 superinvestors Shameless Cloning tracks reported Novartis AG (NVS) in their Q2 2026 13F filings, worth $136.8M combined, at an average 0.3% of their portfolios. The largest positions by portfolio weight belong to Tweedy Browne (0.8%), Kahn Brothers Group (0.3%), Dodge & Cox Funds (0.1%).
Reporting managers
This is a historical 13F snapshot, not a live shareholder register. The count covers all matched managers; dashboard rankings use only those with at least 95% coverage. Reported value is measured at filing quarter-end, not at today's price.
| Manager / SEC filer | % of portfolio | Reported value |
|---|---|---|
| Tweedy BrowneTweedy, Browne Co LLC | 0.8% | $11.1M |
| Kahn Brothers GroupKAHN BROTHERS GROUP INC | 0.3% | $2.1M |
| Dodge & Cox FundsDodge & Cox | 0.1% | $119.0M |
| Lee AinslieMAVERICK CAPITAL LTD | 0.0% | $4.4M |
| Sarah KettererCAUSEWAY CAPITAL MANAGEMENT LLC | 0.0% | $235K |